Header Logo

Connection

SHAWN HIRSCH to Cross-Over Studies

Back to Details
This is a "connection" page, showing publications SHAWN HIRSCH has written about Cross-Over Studies.
SHAWN HIRSCH
Connection Strength
0.208
Cross-Over Studies
  1. Dexmedetomidine HCL (BXCL501) as a potential treatment for alcohol use disorder and comorbid PTSD: A phase 1b, placebo-controlled crossover laboratory study. Am J Addict. 2025 Jan; 34(1):7-14.
    View in: PubMed
    Score: 0.208
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.